REGN

VIE · Equity

Regeneron Pharmaceuticals, Inc.

AT Healthcare Biotechnology

Latest week
29 May 2026
Close
529.400024
Fair value
708.432247
Expectation
Undecided 50.76%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
529.40
12-Week Change
-21.46%
Trend Signal
Inactive
Expectation
Undecided 50.76%
Signal Weeks
7 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-22.74
Market Dynamics
-1.40

Over the latest 12 completed weeks ending 2026-05-29, REGN fell 21.46%, moving from 674.02 to 529.40. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 7 of the last 12 weeks. Relative Strength is -22.74 and has softened across the 12-week window. Market Dynamics is -1.40 on the latest week. Expectation is undecided at 50.76%.